1. How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry. (25th October 2018) Authors: Patriquin, Christopher J.; Kiss, Thomas; Caplan, Stephen; Chin‐Yee, Ian; Grewal, Kuljit; Grossman, Jennifer; Larratt, Loree; Marceau, Daniele; Nevill, Tom; Sutherland, D. Robert; Wells, Richard A.; Leber, Brian Journal: European journal of haematology Issue: Volume 102:Number 1(2019) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy. (22nd March 2016) Authors: Ma, Kim; Caplan, Stephen Other Names: Ohsaka Akimichi Academic Editor. Journal: Case reports in hematology Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia. Issue 7 (6th June 2020) Authors: Assouline, Sarit; Amrein, Lilian; Aloyz, Raquel; Banerji, Versha; Caplan, Stephen; Owen, Carolyn; Hasegawa, Wanda; Robinson, Sue; Shivakumar, Sudeep; Prica, Anca; Peters, Anthea; Hagerman, Linda; Rodriguez, Laura; Skamene, Tanya; Panasci, Lawrence; Chen, Bingshu E.; Hay, Annette E. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 7(2020) Page Start: 1653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The effectiveness and safety of fixed low‐dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin (CME). Issue 7 (15th October 2012) Authors: Varga, Cindy; Al‐Touri, Sultan; Papadoukakis, Stella; Caplan, Stephen; Kahn, Susan; Blostein, Mark Journal: Transfusion Issue: Volume 53:Issue 7(2013) Page Start: 1451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186. Issue 4 (April 2013) Authors: Macdonald, David A.; Assouline, Sarit E.; Brandwein, Joseph; Kamel-Reid, Suzanne; Eisenhauer, Elizabeth A.; Couban, Stephen; Caplan, Stephen; Foo, Alison; Walsh, Wendy; Leber, Brian Journal: Leukemia & lymphoma Issue: Volume 54:Issue 4(2013:Apr.) Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗